Related Experiment Videos
AIDS-associated Kaposi's sarcoma: variables associated with survival.
P L Myskowski1, D Niedzwiecki, B A Shurgot
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Journal of the American Academy of Dermatology
|June 1, 1988
Summary
Prognosis for Kaposi
Area of Science:
- Oncology
- Immunology
- Infectious Diseases
Background:
- Acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (KS) is a significant opportunistic malignancy.
- Identifying prognostic factors is crucial for managing patients with AIDS-KS.
- Previous studies have explored various clinical and immunological markers.
Purpose of the Study:
- To retrospectively analyze prognostic variables in patients with AIDS-associated Kaposi's sarcoma.
- To identify factors influencing survival in this patient population.
Main Methods:
- Retrospective analysis of records from 187 consecutive patients with AIDS-associated KS.
- Multivariate analysis was employed to assess the impact of prognostic variables on survival.
- Key variables included initial site of disease and T cell ratios.
Main Results:
- Initial disease site significantly impacted survival; lower extremity or lymph node lesions correlated with longer survival (p=0.005, p=0.01).
- Higher helper/suppressor T cell ratios were strongly associated with improved survival (p<0.0001).
- Age and cytomegalovirus IgG antibody levels did not show a significant correlation with survival.
Conclusions:
- Distinct patient subgroups exist within AIDS-associated Kaposi's sarcoma.
- Initial disease presentation site and specific immunologic parameters are valuable prognostic indicators.
- These findings can aid in stratifying patients and guiding treatment strategies.